Should we move dementia research funding from a cure to its care?

Gloria Wong and Martin Knapp

LSE Research Online Documents on Economics from London School of Economics and Political Science, LSE Library

Keywords: dementia; research funding; disease-modifying medication; wellbeing; quality of life; cost-effectiveness; equity (search for similar items in EconPapers)
JEL-codes: N0 (search for similar items in EconPapers)
Pages: 3 pages
Date: 2020-04-02
New Economics Papers: this item is included in nep-ore
References: View complete reference list from CitEc
Citations:

Published in Expert Review of Neurotherapeutics, 2, April, 2020, 20(4), pp. 303 - 305. ISSN: 1473-7175

Downloads: (external link)
http://eprints.lse.ac.uk/103760/ Open access version. (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ehl:lserod:103760

Access Statistics for this paper

More papers in LSE Research Online Documents on Economics from London School of Economics and Political Science, LSE Library LSE Library Portugal Street London, WC2A 2HD, U.K.. Contact information at EDIRC.
Bibliographic data for series maintained by LSERO Manager ().